NCT Number: NCT02884232
Application of Guidelines for Medico-professional Supervision of Workers Exposed to Carcinogenic Action of Wood Dust: CERBois Cohort
The purpose is to evaluate feasibility of medical supervision of professionally active asymptomatic wood workers with questionnaires and nasofibroscopy.
Secondary purposes are:
* Feasibility evaluation of identification of former and actual professional expositions to wood dust and to various naso-sinusal carcinogenics in case of co-expositions (formaldehyde, chrome, nickel, leather) * Description of abnormal symptoms identified by occupational doctor and needing an otorhinolaryngology test * Description of results and examinations induced by nasofibroscopy in symptomatic or asymptomatic individuals: counting of naso-sinusal adenocarcinoma cases * Evaluation of participation of workers retiring in 2 years after inclusion to medical supervision program * Evaluation of information flow among different players * Assessment of costs induced by this targeted screening: direct medical costs (screened pathologies, induced additional examinations…) and indirect costs for company (duration of worker absence for transfer, medical and additional examinations).
Looking for future studies?
Notify MeKey information
Conditions
Age range
44 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
AHI 33, Bordeaux, France
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Employee or craftsman
- Actual or former professional exposition to wood dust
- Onset of exposition to wood dust back to more than 30 years (latency >30 years)
- Cumulated exposition to wood dust longer than 12 months
- Exposition to wood dust during machining tasks (sawing, milling, planing, drilling, bridging) or all documented activities exposing to wood dust concentration > 1 mg/m3 for 8 hours
- Worker followed by occupational doctor of participant occupational health departments
- Worker accepting medico-professional supervision recommended by guidelines
- Affiliation to social security
Exclusion criteria
- Difficulty with comprehension of wood auto-questionnaire
Treatment and study plan
Primary outcomes
-
Participation to medical supervision program of professionally active asymptomatic workers
Time frame: Day 0
-
Participation to medical supervision program of professionally active asymptomatic workers
Time frame: 3 months
-
Participation to medical supervision program of professionally active asymptomatic workers
Time frame: 24 months
-
Participation to medical supervision program of professionally active asymptomatic workers
Time frame: 27 months
Secondary outcomes
-
Former and actual professional expositions to wood dust and to various naso-sinusal carcinogenics
Time frame: Day 0
-
Presence of abnormal symptoms assessed by doctor, needing an otorhinolaryngology test
Time frame: Day 0
-
Presence of abnormal symptoms assessed by doctor, needing an otorhinolaryngology test
Time frame: 24 months
-
Counting of diagnoses of naso-sinusal adenocarcinoma in symptomatic and asymptomatic workers after nasofibroscopy
Time frame: 3 months
-
Counting of diagnoses of naso-sinusal adenocarcinoma in symptomatic and asymptomatic workers after nasofibroscopy
Time frame: 27 months
-
Participation to medical supervision program of workers retiring in 2 years after inclusion
Time frame: Day 0
-
Evaluation of information flow among different players
Time frame: 3 months
-
Evaluation of information flow among different players
Time frame: 27 months
-
Medical costs Induced by screening
Time frame: 3 months
-
Medical costs Induced by screening
Time frame: 27 months
Sponsors and collaborators
Lead sponsor
Central Hospital, Nancy, France
Other
Registry information
Official study title
Application of Guidelines for Medico-professional Supervision of Workers Exposed to Carcinogenic Action of Wood Dust: CERBois Cohort. Feasibility Evaluation
Acronym: CERBois
Important dates
- Study start
- 2012
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- Aug 30, 2016
- Registry last updated
- Aug 30, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.